Perachon, S., Schwartz, J.-C. and Sololoff, P. (1999) Fuctional Potencies of New Antiparkinsonian Drugs at Recombinant Human Dopamine D1, D2 and D3 Receptors. European Journal of Pharmacology, 366, 293-300. https://doi.org/10.1016/S0014-2999(98)00896-6

has been cited by the following article:

• TITLE: Pathological Gambling after Administration of Pramipexole

  AUTHORS: Konstantinos Kontoangelos, Marina Ecomomou, Charalambos Papageorgiou

  KEYWORDS: Pramipexole, Pathological Gambling, Side Effects, Parkinson Disease

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 24, 2018

  ABSTRACT: Parkinson’s disease is a common condition usually treated by dopaminergic agents and many behavioral abnormalities such as impulse control disorders (ICD) are connected with that usage. Pathological gambling, a form of ICD includes is a clinical condition that disrupts personal, family and occupational activity. Pramipexole a D2 AND D3 agonist may be associated with pathological gambling. We present a case of 74-year-old male patient who was diagnosed with Parkinson’s disease (PD). His doctor advised him to take pramipexole 0.18 mg/p.o./day. A month after the onset of treatment he manifested a behavior of pathological gambling. After the discontinuation of the drug all this behavior was interrupted.